Xylometazoline Hydrochloride
- C16H24N2.ClH
- C16H25ClN2
- Xylometazoline hydrochloride
- 1218-35-5
- Xylometazoline HCl
- Xylometazoline (hydrochloride)
- 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride
- Create:2005-10-11
- Modify:2025-01-18
- 2-(4'-tert-butyl-2',6'-dimethylphenylmethyl)imidazoline
- Amidrin
- Balkis
- Chlorohist-LA
- Decongest
- espa-rhin
- Gelonasal
- Idasal
- Idril N
- Imidin
- Nasan
- Nasengel AL
- NasenGel ratiopharm
- Nasenspray AL
- NasenSpray ratiopharm
- Nasentropfen AL
- NasenTropfen ratiopharm
- Novorin
- Otradrops
- Otraspray
- Otriven
- Otrivin
- Otrivin Mentol
- Rapako
- schnupfen endrine
- Snup
- stas
- xylometazoline
- xylometazoline hydrochloride
- xylometazoline monohydrochloride
- Xylometazoline hydrochloride
- 1218-35-5
- Xylometazoline HCl
- Xylometazoline (hydrochloride)
- 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride
- Neo-Synephrine II
- Otrivin hydrochloride
- MFCD00238707
- Rhinactin
- NSC-757378
- Olynth
- DTXSID3045223
- 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1)
- MLS000069695
- DTXCID1025223
- X5S84033NZ
- Xylometazoline hydrochloride (USP)
- UNII-X5S84033NZ
- SMR000058526
- EINECS 214-936-4
- 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline monohydrochloride
- 2-(4-(tert-butyl)-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole hydrochloride
- 1H-Imidazole, 2-((4-(1,1-dimethylethyl)-2,6-dimethylphenyl)methyl)-4,5-dihydro-, monohydrochloride
- 2-(4-tert-butyl-2,6-dimethylbenzyl)-4,5-dihydro-1h-imidazole hydrochloride
- XYLOMETAZOLINE HYDROCHLORIDE (MART.)
- XYLOMETAZOLINE HYDROCHLORIDE [MART.]
- XYLOMETAZOLINE HYDROCHLORIDE (USP-RS)
- XYLOMETAZOLINE HYDROCHLORIDE [USP-RS]
- NSC 757378
- 2-IMIDAZOLINE, 2-(4-tert-BUTYL-2,6-DIMETHYLBENZYL)-, MONOHYDROCHLORIDE
- SR-01000000230
- XYLOMETAZOLINE HYDROCHLORIDE (EP MONOGRAPH)
- XYLOMETAZOLINE HYDROCHLORIDE [EP MONOGRAPH]
- NCGC00016101-02
- 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, monohydrochloride
- XYLOMETAZOLINE HYDROCHLORIDE (USP MONOGRAPH)
- XYLOMETAZOLINE HYDROCHLORIDE [USP MONOGRAPH]
- CAS-1218-35-5
- XYLOMETAZOLINEHYDROCHLORIDE
- Prestwick_574
- SinosilNasal Decongestant
- Opera_ID_1744
- Metarivin Soln. 0.1%
- Neo-Synephrine II (TN)
- SCHEMBL41837
- MLS001076518
- SPECTRUM1500614
- CHEMBL1256400
- HY-B0475R
- REGID_for_CID_5282386
- HMS1568N07
- HMS1921K09
- Pharmakon1600-01500614
- Xylometazoline Hydrochloride ,(S)
- BCP22148
- HY-B0475
- Tox21_110305
- Tox21_501269
- CCG-39900
- NSC757378
- s2576
- AKOS015895456
- Tox21_110305_1
- AC-8301
- KS-5144
- LP01269
- NCGC00016101-10
- NCGC00094506-01
- NCGC00094506-02
- NCGC00094506-03
- NCGC00094506-04
- NCGC00094506-05
- NCGC00261954-01
- XYLOMETAZOLINE HYDROCHLORIDE [MI]
- Xylometazoline (hydrochloride) (Standard)
- XYLOMETAZOLINE HYDROCHLORIDE [VANDF]
- EU-0101269
- NS00081176
- SW196748-3
- X0063
- XYLOMETAZOLINE HYDROCHLORIDE [WHO-DD]
- D00757
- X 6000
- Xylometazoline hydrochloride, analytical standard
- J-004686
- SR-01000000230-2
- SR-01000000230-7
- Q27293585
- Z2242061948
- Xylometazoline hydrochloride, British Pharmacopoeia (BP) Reference Standard
- Xylometazoline hydrochloride, European Pharmacopoeia (EP) Reference Standard
- Xylometazoline hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
- Xylometazoline hydrochloride, United States Pharmacopeia (USP) Reference Standard
245.201309 100
246.204239 14.44
189.138672 10.07
175.146378 9.09
229.167542 6.34
P264, P270, P301+P316, P321, P330, P405, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 74 reports by companies from 6 notifications to the ECHA C&L Inventory.
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
IMAP assessments - 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, monohydrochloride: Environment tier I assessment
IMAP assessments - 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, monohydrochloride: Human health tier I assessment
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=YGWFCQYETHJKNX-UHFFFAOYSA-N
- Australian Industrial Chemicals Introduction Scheme (AICIS)1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, monohydrochloridehttps://services.industrialchemicals.gov.au/search-assessments/1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, monohydrochloridehttps://services.industrialchemicals.gov.au/search-inventory/
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/Xylometazoline hydrochloridehttps://commonchemistry.cas.org/detail?cas_rn=1218-35-5
- DTP/NCILICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseXylometazoline hydrochloridehttps://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=757378
- EPA Chemicals under the TSCA1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1)https://www.epa.gov/chemicals-under-tscaEPA TSCA Classificationhttps://www.epa.gov/tsca-inventory
- EPA DSSToxXylometazoline hydrochloridehttps://comptox.epa.gov/dashboard/DTXSID3045223CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-noticeXylometazoline hydrochloridehttps://echa.europa.eu/substance-information/-/substanceinfo/100.013.579Xylometazoline hydrochloride (EC: 214-936-4)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/122782
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingXYLOMETAZOLINE HYDROCHLORIDEhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/X5S84033NZ
- New Zealand Environmental Protection Authority (EPA)LICENSEThis work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International licence.https://www.epa.govt.nz/about-this-site/general-copyright-statement/
- CCSbaseCCSbase Classificationhttps://ccsbase.net/
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- ClinicalTrials.govLICENSEThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
- DailyMedXYLOMETAZOLINE HYDROCHLORIDEhttps://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=XYLOMETAZOLINE+HYDROCHLORIDE
- Drug Gene Interaction database (DGIdb)LICENSEThe data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.http://www.dgidb.org/downloadsXYLOMETAZOLINE HYDROCHLORIDEhttps://www.dgidb.org/drugs/rxcui:54220
- EU Clinical Trials Register
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlAnatomical Therapeutic Chemical (ATC) classificationhttp://www.genome.jp/kegg-bin/get_htext?br08303.kegTarget-based classification of drugshttp://www.genome.jp/kegg-bin/get_htext?br08310.keg
- MassBank of North America (MoNA)LICENSEThe content of the MoNA database is licensed under CC BY 4.0.https://mona.fiehnlab.ucdavis.edu/documentation/license
- National Drug Code (NDC) DirectoryLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingXYLOMETAZOLINE HYDROCHLORIDEhttps://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- NLM RxNorm TerminologyLICENSEThe RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.htmlxylometazoline hydrochloridehttps://rxnav.nlm.nih.gov/id/rxnorm/54220
- SpectraBaseXylometazoline hydrochloridehttps://spectrabase.com/spectrum/AbR95l4WTmBXylometazoline hydrochloridehttps://spectrabase.com/spectrum/FmIJOqFrl2iXylometazoline hydrochloridehttps://spectrabase.com/spectrum/8mC3tWj01RF
- Springer Nature
- Wikidataxylometazoline hydrochloridehttps://www.wikidata.org/wiki/Q27293585
- PubChem
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlxylometazolinehttps://www.ncbi.nlm.nih.gov/mesh/67009695Nasal Decongestantshttps://www.ncbi.nlm.nih.gov/mesh/68014663
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/NORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- EPA Substance Registry ServicesEPA SRS List Classificationhttps://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 388470138https://pubchem.ncbi.nlm.nih.gov/substance/388470138